| Quick Answer |
| Surgery brings the larger, more durable loss, often a quarter of body weight or more, but it is permanent and needs lifelong follow-up. GLP-1 medicines can help users lose up to 20% of their body weight without an operation, though weight tends to return when they stop. Indian guidelines consider surgery from BMI 35, or lower with diabetes. |
Two people walk into the same Pune clinic. Both have a BMI of 36 and both have type 2 diabetes. One leaves with a date for a sleeve gastrectomy, the other with a prescription for a weekly injection.
Neither doctor got it wrong. The decision between bariatric surgery and medication turns on things a weighing scale cannot show, such as how much weight has to come off and what kind of lifelong commitment suits the person standing on it.
More Indians are facing this choice every year. The latest National Family Health Survey (NFHS-6, 2023-24) found 30.7% of women and 27.3% of men aged 15 to 49 are overweight or obese, up from 24% and 22.9% five years earlier.
India also draws the line lower than Western charts. A 2025 revision by Misra and colleagues treats a BMI above 23 as the starting point of obesity in Indian adults, and Indian guidance flags a waist of 90 cm or more in men and 80 cm or more in women.
The Decision at a Glance
Surgery and medication solve the same problem from opposite ends. One changes the anatomy of the gut once and for all. The other changes the signals the gut sends to the brain, for as long as the medicine is taken.
The table below sets them side by side on the questions people ask most.
| Question | Bariatric surgery | GLP-1 medication |
| How it works | Makes the stomach smaller and, in bypass operations, reroutes part of the gut | A weekly injection that copies a gut hormone telling the brain you are full |
| Weight loss | Roughly a quarter or more in the first few years, settling to about a fifth by five | Up to 20% of body weight in trials |
| Who it suits in India | Highly recommended from BMI 35; possible from BMI 30 with poorly controlled diabetes or other conditions | Adults a doctor assesses using Indian BMI and waist thresholds |
| Main risks | Rare surgical complications, vitamin and mineral deficiencies, reflux | Nausea, constipation, gallbladder problems, muscle loss without enough protein |
| If you stop | The operation stays; some regain over the years is common | About two-thirds of lost weight returns within a year |
| Cost shape | One large upfront bill, then lifelong supplements and tests | A smaller recurring cost for as long as treatment continues |
| Insurance | Covered under IRDAI rules for BMI 40, or 35 with conditions | Given outside hospital, so check your OPD cover |
Who Qualifies for Bariatric Surgery in India
Indians qualify for surgery at a lower BMI than Europeans, because excess fat harms the Indian body sooner. Asian Indians tend to carry more fat deep among the organs at the same weight, which pushes up diabetes and heart risk earlier.
The national surgical society has written this into its rules. The OSSI Guidelines for Bariatric and Metabolic Surgery 2026, which replaced the society’s earlier editions this year, set the bar well below the old Western cut-offs of 40, or 35 with a related illness.
| Your situation | What Indian guidelines say |
| BMI 37.5 or above | Strongly recommended, with or without other conditions |
| BMI 35 to 37.4 | Highly recommended, with or without other conditions |
| BMI 32.5 to 34.9 | Recommended if you have at least one significant weight-related condition |
| BMI 30 to 32.4 | May be recommended if type 2 diabetes or metabolic syndrome stays poorly controlled |
| BMI 27.5 to 29.9 | May be recommended for a life-threatening condition such as severe sleep apnoea; for diabetes alone, only within an approved research study |
| BMI below 27.5 | Only within a research study approved by an ethics committee and ICMR |
| Waist 90 cm (men) or 80 cm (women) and above | Can support surgery at the lower end of the BMI range when weight-related conditions are present |
| Age 18 to 65 | The standard range; above 65, considered when weight-related illness or disability is severe |
Eligibility also has a commitment test. The same guidelines rule out surgery for anyone who cannot keep up long-term follow-up or take nutritional supplements for life, and during pregnancy and breastfeeding.
A detail that surprises most people: India has been described as the largest hub for bariatric surgery in Asia. In OSSI’s national data, the sleeve gastrectomy is the most common operation, and the one-anastomosis or “mini” gastric bypass, rare in many Western centres, comes second.
Weight Loss Results Compared
Surgery produces more weight loss on average, and the gap is wide. In a 2025 JAMA Surgery comparison of adults with a BMI of 40 or more, people who had surgery had lost about 28% of their body weight by their last recorded check-up, most of them followed for close to three years. Those treated with medication in routine care lost far less.
Medication has closed some of that gap in trials. In the SURMOUNT-1 trial, adults on a GLP-1-based medicine lost up to 20% of their body weight. For someone weighing 90 kg, that is up to 18 kg, close to the weight of four 5-litre cans of cooking oil.
Trial results and everyday results are not the same thing. Trials keep people on the full dose with regular check-ins, while in real life some people stop early or never reach the dose that works for them.
Effect on Diabetes and Other Conditions
Both treatments can transform blood sugar, and this matters in India more than almost anywhere. NFHS-6 found that 20.9% of men and 17.8% of women aged 15 and above have high blood sugar or take medicine for it.
The strongest long-term evidence for surgery comes from the STAMPEDE trial. Five years on, 29% of people who had a gastric bypass and 23% after a sleeve kept their HbA1c at 6% or lower, against just 5% on medical care alone.
There is a twist worth knowing. A bypass works partly by raising the body’s own GLP-1 after every meal, which is the same hormone the injections copy. Surgery and medication pull on some of the same levers.
Beyond sugar, losing a meaningful amount of weight by either route tends to ease blood pressure, fatty liver, sleep apnoea and knee pain. The bigger the loss, the bigger the effect, which is where surgery holds its edge.
Risks of Each
Surgery carries a small risk of serious harm up front and a long tail of nutritional care. Medication carries frequent but mostly mild side effects that last as long as treatment does.
Surgical risks
Modern keyhole bariatric surgery is far safer than its reputation. In large registries, death within 30 days is about 1 in 1,000 or lower after a sleeve, and a leak from the staple line affects fewer than 1 in 100 people.
The longer-term risks are quieter. Deficiencies of iron, vitamin B12, vitamin D and calcium are common without lifelong supplements and blood tests, and anaemia can creep in over years.
Indian diets add a wrinkle. With many people vegetarian, getting enough protein and B12 from a much smaller stomach takes planning, often with a dietician, because two rotis and a katori of dal may be all that fits in a meal.
Medication side effects
Most side effects of GLP-1 medicines are digestive: nausea, fullness, constipation or loose motions. They tend to peak when the dose is increased and settle over the following weeks.
In the SURMOUNT-1 trial, fewer than 1 in 10 people stopped because of side effects. Rarer problems include gallstones and inflammation of the pancreas (pancreatitis).
Every GLP-1 medicine in India is prescription only. Dose, duration and any change of plan belong with a doctor who is monitoring you.
Cost Compared
The two options differ more in the shape of the cost than in a single number. Surgery is one large bill at the start. Medication is a smaller cost that repeats for as long as you stay on it.
The surgical bill usually covers tests before the operation, the procedure itself and a short hospital stay. What it leaves out is the long tail: vitamins and minerals for life, plus regular blood tests and follow-up visits.
Medication costs change with time. Doses rise over the first months, and because weight tends to return after stopping, many people need treatment for years rather than months.
GLP-1 treatment is given outside hospital, and most standard policies are built for hospital stays. Check the OPD (day-care and consultation) terms of your own policy before assuming either way.
Reversibility and Long-Term Commitment
A sleeve gastrectomy cannot be undone, because most of the stomach is removed. A bypass can technically be reversed, but it is a complex operation that is rarely done.
Medication is the opposite. You can stop at any point, and in the STEP 1 trial extension, people who stopped their weekly injection regained two-thirds of the weight they had lost within a year.
That makes both paths long-term commitments, just of different kinds. Surgery asks for lifelong supplements and check-ups. Medication asks for ongoing treatment, adjusted by a doctor, for as long as the benefit is needed.
Our Take: Which Path Fits Whom
Our view is that BMI opens the conversation but should not end it. The right path follows from three practical questions: how much weight you need to lose for your health to change, whether your diabetes is already hard to control, and whether you can live with a permanent change to your gut.
Use the table as a starting point for that conversation with your doctor, not as a verdict.
| If this sounds like you | Usually discussed first | Why |
| BMI 23 to 27.5, or waist above 90 cm (men) or 80 cm (women), with early metabolic changes | Lifestyle, then medication if needed | Surgery is outside Indian guidelines at this level |
| BMI 27.5 to 30 with diabetes still uncontrolled on treatment | Medication | Surgery for diabetes alone is limited to research studies at this level |
| BMI 30 to 35 with poorly controlled diabetes or another significant condition | Either, after a full assessment | Both are within guidelines; your goals decide |
| BMI 35 and above, especially with diabetes | Surgery is a strong option | It offers the largest, most lasting loss |
| Very high BMI or high surgical risk | Medication first, surgery later | Losing some weight first can make an operation safer |
| Cannot commit to lifelong supplements and follow-up, or planning a pregnancy soon | Medication | Guidelines advise against surgery in these cases |
Before your appointment, write down your weight history and the conditions you are being treated for. Ask your doctor how much weight loss would change those conditions. Then ask which path gets you there with risks you can accept.
Combining Both
Surgery and medication increasingly work as partners rather than rivals. A 2026 joint treatment algorithm from the Endocrine Society of India and India’s obesity surgeons sets out when to use each, and when to switch.
For milder disease, the experts prefer medication as the first add-on to lifestyle change. For the most severe stage, they prefer surgery, often with medication beforehand to bring weight and surgical risk down.
There is a biological reason this works. Research on people who respond poorly to a sleeve points to a weak natural GLP-1 response after meals, and in a randomised trial of such people, adding a GLP-1 medicine produced meaningful extra weight loss compared with placebo.
Combining them means more monitoring, not less. A smaller stomach plus a medicine that dampens appetite can push protein and fluid intake too low, so the surgical team and the prescribing doctor need to plan it together.
| Conclusion |
| Bariatric surgery gives the biggest and most durable weight loss, and Indian guidelines open it to people at a lower BMI than Western rules. The trade is permanence, lifelong supplements and a small surgical risk. GLP-1 medication can help users lose up to 20% of their body weight without an operation, but the benefit tends to fade once treatment stops. For many people the answer is one, then the other, chosen with a doctor who knows their history. |
Frequently Asked Questions
1. Should I have surgery or take medication?
It depends on your BMI, your health conditions and how much weight you need to lose. Surgery gives larger, longer-lasting loss and suits people with a BMI of 35 or above or hard-to-control diabetes. Medication suits people at lower BMIs or who want to avoid an operation. A doctor should make this call with you.
2. Who qualifies for bariatric surgery in India?
Under the 2026 OSSI guidelines, surgery is highly recommended for adults aged 18 to 65 with a BMI of 35 or above. It is recommended from a BMI of 32.5 with a significant weight-related condition, and may be offered from a BMI of 30 when type 2 diabetes stays poorly controlled despite treatment. A waist of 90 cm in men or 80 cm in women can support the case when weight-related conditions are present.
3. How do weight loss results compare?
Surgery usually produces more weight loss, roughly a quarter of body weight or more in the first few years. GLP-1 medicines can help users lose up to 20% of their body weight in trials. Weight tends to return after medication stops, while surgery keeps working, although some regain is common over five years.
4. What are the main surgical risks?
Serious complications are uncommon, with death within 30 days about 1 in 1,000 or lower after a sleeve and leaks affecting fewer than 1 in 100 people. The longer-term risks are deficiencies of iron, vitamin B12, vitamin D and calcium, plus reflux after a sleeve and dumping after a bypass. Lifelong supplements and blood tests manage most of them.
5. Can I take a GLP-1 instead of surgery?
For many people, yes. If your BMI or health does not call for surgery, or you prefer not to have an operation, a doctor-guided GLP-1 programme is a valid alternative. It works only while you take it, so plan for long-term treatment. Indian surgical guidelines add that medication should not replace surgery for people who clearly meet surgical criteria and are fit for an operation.
| Medical Disclaimer |
| This article is for general education and is not a substitute for medical advice, diagnosis or treatment. Bariatric surgery and GLP-1 medicines are suitable only for people a qualified doctor has assessed. GLP-1 medicines are prescription-only in India. Do not start, stop or change any treatment without speaking to your doctor. |